1-3 of 3
Ulrich Keilholz, MD
Close
Sort by
Journal Articles

Analysis of Immunological and Clinical Response Kinetics to WT1 Peptide Vaccine in Patients with AML and MDS: Need for Supplementation of IWG Response Criteria?.

Ulrich Keilholz, MD, Anne Letsch, MD, Antonia Busse, MD, Annemarie Asemissen, MD, Igor W. Blau, MD, Wolf K. Hofmann, MD, Lutz Uharek, MD, Eckhard Thiel, MD, Carmen Scheibenbogen, MD
Journal: Blood
Blood (2007) 110 (11): 902.
https://doi.org/10.1182/blood.V110.11.902.902
Published: 2007
Journal Articles

Clinical and Immunological Activity of WT1 Peptide Vaccination in Patients with Acute Myeloid Leukemia and Myelodysplasia: Results of a Phase II Trial.

Ulrich Keilholz, MD, Anne Letsch, Antonia Busse, Anne M. Asemissen, Alexander Schmittel, Wolf K. Hofmann, Lutz Uharek, Igor W. Blau, Eckhard Thiel, Carmen Scheibenbogen
Journal: Blood
Blood (2006) 108 (11): 567.
https://doi.org/10.1182/blood.V108.11.567.567
Published: 2006
Journal Articles

Quantitative Analysis of Wilms’ Tumor Gene 1(WT1) Expression in Acute Lymphoblastic Leukemia (ALL) of Adults Reveals Lower WT1 Levels Than in Acute Myeloid Leukemias (AML) and Varying Expression Levels between Individual Patients among Different ALL Subgroups.

Jan M. Siehl, MD, Eckhard Thiel, MD, Dieter Hoelzer, MD, Stefan Schwartz, MD, Ulrich Keilholz, MD
Journal: Blood
Blood (2005) 106 (11): 4545.
https://doi.org/10.1182/blood.V106.11.4545.4545
Published: 2005